Aliaga-Gaspar, P., Hurtado Guerrero, I., Ciano-Petersen, N. L., Urbaneja, P., Brichette-Mieg, I., Reyes, V., . . . Ramió-Torrentà, L. (2021). Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.
Citación estilo ChicagoAliaga-Gaspar, Pablo, Isaac Hurtado Guerrero, Nicolás Lundahl Ciano-Petersen, Patricia Urbaneja, I. Brichette-Mieg, Virginia Reyes, Ester Quintana, y Lluís Ramió-Torrentà. Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment. 2021.
Cita MLAAliaga-Gaspar, Pablo, et al. Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment. 2021.